Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysisFaizan Khan, Marc Rodger, Sabine Eichinger et al.|BMJ|2019Cited by 312
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysisTrevor Baglin, Alfonso Iorio, James D. Douketis et al.|Journal of Thrombosis and Haemostasis|2010Cited by 209
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)C.Y. VOSSEN, Frits R. Rosendaal, J. Conard et al.|Journal of Thrombosis and Haemostasis|2005Cited by 202
Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin, Protein C, Protein S Deficiency, or Activated Protein C ResistancePaolo Bucciarelli, Roberto Quintavalla, Frits R. Rosendaal et al.|Arteriosclerosis Thrombosis and Vascular Biology|1999Cited by 161